10 October 2023, Cannes, France: EZZ Life Science (ASX: EZZ), a genomic life science company with a mission to improve quality of life and human health, has exhibited at the prestigious TFWA World Exhibition and Conference in Cannes, France. The company’s participation in one of the world’s largest gatherings of professionals from the duty free and travel retail sectors marks the company’s potential expansion into Europe as it continues to enhance its presence on the world stage.
EZZ has been adding to its distribution channels and geographies as it continues its global expansion. Over the past year, the company has successfully added new distribution channels to its e-commerce strategy, including prominent platforms such as Amazon, eBay, and Chinese short video platform Kuaishou. This strategic move has allowed consumers around the world greater access to EZZ’s high quality ranges of healthcare, haircare and skincare products.
EZZ’s global footprint is already substantial, with products distributed in more than 20 countries worldwide. Key markets include Australia, China, New Zealand, Vietnam, and Singapore, where the brand has become synonymous with quality and efficacy. However, participation in the TFWA World Exhibition and Conference marks the company’s first efforts to enter Europe’s estimated $38.2 billion dietary supplement market.
Glenn Cross, Chair of EZZ Life Science, said, “EZZ’s participation in the TFWA World Exhibition and Conference for the first time highlights our commitment to exploring and seizing new avenues for growth. This marks a significant milestone in our journey, and we are eager to introduce our brand, values, and groundbreaking products to the European market.”
As the duty free and travel retail sector’s largest annual gathering, the TFWA World Exhibition & Conference offers an unrivalled scope for mixing with key industry decision-makers.
EZZ Life Sciences aims to empower individuals to lead healthier, more vibrant lives. Through exploring its expansion into the European market and beyond, EZZ is poised to extend its offerings to a global audience, reaching even more consumers across the world.
About EZZ Life Science
EZZ Life Science Holdings Limited (ASX:EZZ) is a genomic life science company with a mission to improve quality of life and human health.
EZZ Life Science has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. EZZ Life Science is passionate about investing in the future of consumer health through the development of e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China and worldwide.
